Gotham Therapeutics Corp.

As venture capital financings for biopharmaceutical companies continues to head into record-breaking territory again in 2021, Illumina Ventures and Jeito Capital announced two new venture capital fund

The California Institute of Regenerative Medicine (CIRM), which uses $3bn worth of state bond revenue to provide grants and loans for the development of stem cell therapies, approved a $6.2m funding a

Series A Round Brings $60m To 89bio Launched with small molecules licensed from Teva Pharmaceutical Industries Ltd. , 89bio concurrently raised $60m through its Series A round. Founding investors O

US venture capital investment in pharmaceutical and biotechnology companies rose from $9.7bn in the first half of 2018 to $14.5bn through the third quarter, beating by a wide margin the $11.9bn raised